Navigation Links
CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Date:4/26/2012

which include revenues of approximately $500,000 related to the use of funds received from the U.S. Department of Defense in connection with the development of BioFoam.  This represents annual total revenue growth of 5 percent to 8 percent.  The Company expects tissue processing revenues to be flat for the full year of 2012 compared to 2011.  Revenues from the Company's higher margin product segment are expected to grow between 10 percent and 15 percent for the full year of 2012.  This includes expectations for BioGlue and BioFoam revenues to increase in the low to mid-single digits on a percentage basis in 2012 compared to 2011, and PerClot revenues to be between $3.5 million and $4.5 million.  The Company expects revenues from revascularization technologies to be between $10.5 million and $11.5 million in 2012.  Research and development expenses are expected to be between $10.0 million and $12.0 million in 2012 as a result of the Company's investments in its U.S. clinical trials for Perclot and BioFoam, along with its European pilot study for TMR with biologics.  The Company expects earnings per share of between $0.14 and $0.18 in 2012, which includes the increased research and development expenses described above, along with increased legal expenses related to the Company's ongoing litigation with Medafor.  The Company's earnings per share guidance excludes expenses related to business development and potential share repurchases, which cannot currently be estimated.  The Company has estimated litigation expense conservatively on the high end of the anticipated range of between $5.0 million and $6.0 million, because litigation expenses are extremely variable and are not easily predicted.

The Company expects the effective income tax rate for 2012 to be in the mid thirty percent range. 

The Company's financial guidance for the full year of fiscal 2012 is subject to the risks described below in the last
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
2. CryoLife Enhances Management Team with Promotions
3. CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
4. CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
5. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial Results
8. CryoLife Provides Update on ValveXchange®, Inc. Investment
9. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
10. CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results
11. CryoLife Makes Equity Investment in ValveXchange® Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... YORK and RALEIGH, N.C., Oct. 20, 2014 ... Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today ... drug candidates for the treatment of the rare ... BioPontis Alliance announced its alliance model earlier ... a first demonstration of a collaborative model where ...
(Date:10/19/2014)... 20, 2014 CTI BioPharma Corp. (CTI) (NASDAQ ... its third quarter 2014 financial results on Wednesday, October ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 ... can be obtained as follows: Wednesday, October ...
(Date:10/19/2014)... FRANKFURT , Deutschland, October 19, 2014 /PRNewswire/ ... echten CRT-Fallstudien gefragt. Das Problem dabei ... ihre Informationen mit der Kompetenz zu teilen. ... zusammenzustellen, und deshalb freuen wir uns umso mehr, ... Pharmafirmen gebeten, ihre Gepflogenheiten bei Kühlketten aufzuschreiben - ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2
(Date:10/20/2014)... It’s hard to imagine what it’s like ... children around the world, it’s a reality. And while new ... are forced to walk barefoot on rocky terrain or sewage-lined ... with their friends. , Buckner International's Shoes for ... in October to encourage support for Air1 and while ...
(Date:10/20/2014)... October 20, 2014 Do you ever ... Here comes a wonderful app Metassessor for teachers, specialists ... company helped its client “Intervention Development LLC” to ... app is designed for iOS 4.3 or later and ... app is optimized for iPhone 5. It is now ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, BambooIndustry.com, ... has unveiled its new range of bamboo deckings ... for these natural items; they are now available at ... most people, it is hard to overstate the significance ... of attention to online services. The company’s workers are ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Having been working ... a good knowledge of customer needs. According to James, one ... covered with dazzling sequins, or with high-low skirts that add ... a huge demand. Recently, LunaDress has unveiled its new selection ... of fact, the company’s brand new items are available in ...
(Date:10/19/2014)... October 20, 2014 SweetDressy.com, a professional ... announced its promotion for long evening dresses . ... the special offer; the current discount is up to ... the industry pioneers in the fashion field. Its dress ... ladies dwelling in various parts of the world. All ...
Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... Senegal, March 25 The U.S. Agency for ... Assistance (OFDA) is providing more than $3.7 million ... increase food security of families in Senegal.Of this ... improve community-based nutrition efforts and agriculture production in ...
... 25 Globus Medical, Inc., the largest privately ... announced the launch of MicroFuse(TM) ST Granules, a ... both strength and porosity. MicroFuse(TM) technology utilizes proprietary ... polymers manufactured with a patented microsphere process to ...
... Several cases of inappropriate shocks from appliances have ... -- A literally shocking tale of the potential ... implanted defibrillators comes from cardiologists in Denmark. , ... receiving an implantable cardioverter defibrillator, was readmitted shortly ...
... NATICK, Mass., March 25 Boston Scientific Corporation (NYSE: ... Poor,s Ratings Services has raised the Company,s rating outlook ... credit rating at BB+.The Standard and Poor,s upgrade follows ... the Company,s outlook to stable from negative.Standard and Poor,s ...
... Neonatologists begin new era of treatment to save tiniest babiesCLEVELAND, March 25 ... NICU provides individual rooms with sleep accommodations so parents can stay ... Innovative care design that creates a healing environment with ... Green building materials incorporated throughout NICU. , ...
... One of the Highest Civilian Honors Given to ... March 25 The Congressional Medal of Honor ... Above & Beyond Citizen Honors recipients for ... process, three Americans have been selected for their ...
Cached Medicine News:Health News:Globus Medical's MicroFuse(TM) Technology Engineered for Optimal Strength and Porosity 2Health News:Faulty Household Wiring Can Trigger a Heart Defibrillator 2Health News:Standard and Poor's Raises Boston Scientific's Rating Outlook to Positive 2Health News:Standard and Poor's Raises Boston Scientific's Rating Outlook to Positive 3Health News:Rainbow Babies & Children's Hospital Opens Most Technologically Advanced NICU in World 2Health News:Rainbow Babies & Children's Hospital Opens Most Technologically Advanced NICU in World 3Health News:Rainbow Babies & Children's Hospital Opens Most Technologically Advanced NICU in World 4Health News:'Above & Beyond Citizen Honors' Announces and Honors 2009 Recipients 2Health News:'Above & Beyond Citizen Honors' Announces and Honors 2009 Recipients 3Health News:'Above & Beyond Citizen Honors' Announces and Honors 2009 Recipients 4
... ,The Cardiocap/5 is a compact, ... the operating room, ambulatory surgery unit, ... offers full vital signs monitoring capabilities ... circulation to advanced airway gas analysis ...
... Releasing the power of clinical information. ... newest generation of clinical connectivity solutions that ... provide effective, high-quality patient care. You will ... be able to share it with your ...
... of clinical information. , ,S/5 Clinical ... connectivity solutions that help you and your ... care. You will have access to essential ... it with your care team and specialists, ...
... Compact and comprehensive solution for ... Arrhythmia Workstation (ARRWS) provides one compact, ... telemetry monitored patients. It connects to ... analysis for up to 16 beds., ...
Medicine Products: